Quick Answer
SINOVAC BIOTECH LTD reported Revenue (ASC 606) of $448.27 million for fiscal year 2023.
SINOVAC BIOTECH LTD Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2023 | $448.27M | -70.0% |
| 2022 | $1.49B | -92.3% |
| 2021 | $19.37B | +3694.4% |
| 2020 | $510.62M | +107.5% |
| 2019 | $246.05M | +7.1% |
| 2018 | $229.65M | +31.7% |
| 2017 | $174.35M | +140.7% |
| 2016 | $72.43M | — |
- SINOVAC BIOTECH LTD showed a decrease of -70.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2023 period, SINOVAC BIOTECH LTD’s revenue (asc 606) has grown by 518.9% (from $72.43 million to $448.27 million).
- The most recent figure is from SINOVAC BIOTECH LTD’s fiscal year 2023 report (Form 20-F), filed with the SEC on April 29, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: